Literature DB >> 4559742

Effects of fraction I from Yersinia pestis on phagocytosis in vitro.

R C Williams, H Gewurz, P G Quie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4559742     DOI： 10.1093/infdis/126.3.235

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  12 in total

1.  Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.

Authors:  Jeremy L Goodin; David F Nellis; Bradford S Powell; Vinay V Vyas; Jeffrey T Enama; Lena C Wang; Patrick K Clark; Steven L Giardina; Jeffery J Adamovicz; Dennis F Michiel
Journal:  Protein Expr Purif       Date:  2006-12-31       Impact factor: 1.650

2.  Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge.

Authors:  G P Andrews; D G Heath; G W Anderson; S L Welkos; A M Friedlander
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

3.  Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trial.

Authors:  Kai Chu; Jialei Hu; Fanyue Meng; Jingxin Li; Li Luo; Jianjun Xu; Zhonghang Yuan; Zhiyong Li; Wangeng Chen; Lei Jiao; Yali Chang; Bingxiang Wang; Yuemei Hu
Journal:  Hum Vaccin Immunother       Date:  2016-05-09       Impact factor: 3.452

4.  Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks.

Authors:  Jian Sha; Janice J Endsley; Michelle L Kirtley; Sheri M Foltz; Matthew B Huante; Tatiana E Erova; Elena V Kozlova; Vsevolod L Popov; Linsey A Yeager; Irina V Zudina; Vladimir L Motin; Johnny W Peterson; Kristin L DeBord; Ashok K Chopra
Journal:  J Clin Microbiol       Date:  2011-03-02       Impact factor: 5.948

5.  Establishment of a Swiss Webster mouse model of pneumonic plague to meet essential data elements under the animal rule.

Authors:  Patricia Fellows; Winston Lin; Carol Detrisac; Shu-Chieh Hu; Narayanan Rajendran; Bruce Gingras; Louis Holland; Jessica Price; Mark Bolanowski; Robert V House
Journal:  Clin Vaccine Immunol       Date:  2012-02-15

6.  Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization.

Authors:  J Hill; S E Leary; K F Griffin; E D Williamson; R W Titball
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

7.  Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague.

Authors:  R W Titball; A M Howells; P C Oyston; E D Williamson
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

Review 8.  Potential human immunotherapeutics for plague.

Authors:  Voahangy Andrianaivoarimanana; Lovasoa Nomena Randriantseheno; Kristoffer M Moore; Nicola J Walker; Steven G Lonsdale; Sarah Kempster; Neil A Almond; Minoarisoa Rajerison; E Diane Williamson
Journal:  Immunother Adv       Date:  2021-10-05

9.  The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague.

Authors:  Florent Sebbane; Clayton Jarrett; Donald Gardner; Daniel Long; B Joseph Hinnebusch
Journal:  Infect Immun       Date:  2008-12-22       Impact factor: 3.441

10.  Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.

Authors:  Philip A Arlen; Michael Singleton; Jeffrey J Adamovicz; Yi Ding; Abdolreza Davoodi-Semiromi; Henry Daniell
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.